NCT00092482 2017-03-22Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)Merck Sharp & Dohme LLCPhase 3 Completed3,882 enrolled